Praxis Precision Medicines, Inc.
Status: Publicly traded
Direct answer
Praxis Precision Medicines, Inc. is publicly traded on NASDAQ under the ticker PRAX.
Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's primary investigational compounds currently undergoing evaluation include: PRAX-114, an extrasynaptic-preferring positive allosteric modulator of the GABAA receptor, which...
Can you invest in Praxis Precision Medicines, Inc.?
Yes. Praxis Precision Medicines, Inc. trades publicly on NASDAQ as PRAX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Praxis Precision Medicines, Inc.
Detailed equity research is provided by MarketSnap.